Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

The reported proportion of 34% of patients with advanced-stage HCC may be misleading, as 41% had extrahepatic disease and 19% had portal vein invasion. Official guidelines 4-6 concur that ...

Combining TACE and SBRT offers a promising treatment for large HCC tumors, addressing TACE's limitations in intermediate-stage cases. Technological advancements have improved SBRT's precision and ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer. Patients with unresectable hepatocellular ...

A retrospective study of the brachial plexus MPNSTs. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text component.

Tumor embolization is a minimally invasive procedure performed few days prior to a planned surgical removal of a tumor. Certain tumors that occur in the brain, neck and spine usually have a large ...